Anti-retroviral and pharmacological properties of 9-(2-phosphonylmethoxyethyl) adenine (PMEA).
Balzarini
J
J
Rega Institute for Medical Research, Leuven, Belgium.
D000225:Adenine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D000263:Adenylate Kinase / Q000378:metabolism; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001711:Biotransformation; D006564:Herpesviridae / Q000187:drug effects; D006801:Humans; D018482:Muscle, Skeletal / Q000201:enzymology; D063065:Organophosphonates; D010766:Phosphorylation; D010770:Phosphotransferases / Q000378:metabolism; D011817:Rabbits; D012190:Retroviridae / Q000187:drug effects*; D013329:Structure-Activity Relationship
D000998:Antiviral Agents; D063065:Organophosphonates; C053001:adefovir; D010770:Phosphotransferases; D000263:Adenylate Kinase; D000225:Adenine